Aspects of the involvement of interleukin-1 and nitric oxide in the pathogenesis of insulin-dependent diabetes mellitus

Cell Death and Differentiation

Volumn 5, Issue 6, 1998, Pages 461-468

  Sjöholm, Åke ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Diabetes mellitus; Insulin secretion; Interleukin 1; Nitric oxide; Pancreatic islet

Indexed keywords

ALPHA TOCOPHEROL; AMINOGUANIDINE; CERAMIDE; CYCLIC AMP; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 70; INSULIN; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; LIPID; LIPOSOME; NICOTINAMIDE; NITRIC OXIDE; PROSTAGLANDIN; PROTEINASE;

APOPTOSIS; CYTOTOXICITY; ENERGY METABOLISM; GENE REPRESSION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; MACROPHAGE; NONHUMAN; PANCREAS ISLET BETA CELL; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

EID: 0031850873     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4400379     Document Type: Review

References (67)

1. Ämmälä C, Eliasson L, Bokvist K, Berggren P-O, Honkanen RE, Sjöholm Å and Rorsman P (1994) Activation of protein kinases and inhibition of protein phosphatases play a central role in the regulation of exocytosis in the pancreatic β-cells. Proc. Natl. Acad. Sci. 91: 4343-4347
2. Ammon HPT and Mark M (1985) Thiols and pancreatic β-cell function: a review. Cell Biochem. Funct 3, 157-171
3. 2+ channels. J. Biol. Chem 269: 2743-2749
4. Bredt DS and Snyder SH (1994) Nitric oxide: aphysiologic messenger molecule. Ann. Rev Biochem. 63: 175-195
5. Chervonsky AV, Wang Y, Wong FS, Visintin I, Flavell RA, Janeway CA Jr, Matis LA (1997) The role of Fas in autoimmune diabetes. Cell 89: 17-24
6. Cooney RV, Franke AA, Harwood PJ, Hatch-Pigott V, Custer LJ and Mordan LJ (1993) γ-Tocopherol detoxification of nitrogen dioxide. Supenonty to α-tocopherol Proc Natl. Acad. Sci. 90: 1771-1775
7. 2 and their formation in rat insulinoma (RINm5F) cells. Free Rad Biol Med. 19: 259-269
8. Corbett JA, Sweetland MA, Lancaster Jr, JR and McDaniel ML (1993a) A1-hourpulse with IL-1β induces formation of nitric oxide and inhibits insulin secretion by rat islets of Langerhans: Evidence for a tyrosine kinase signaling mechanism. FASEB J. 7: 369-374
9. Corbett JA,Kwon G, Turk J and McDaniel ML (1993b) IL-1β induces the coexpression of both nitric oxide synthase and cyclooxygenase by islets of Langerhans: Activation of cyclooxygenase by nitric oxide. Biochemistry 32, 13767-13770
10. Corbett JA, Mikhael A, Shimizu J, Frederick K, Misko TP, McDaniel ML, Kanagawa O and Unanue ER (1993c) Nitric oxide production in islets from nonobese diabetic mice, aminoguanidine-sensitive and -resistant stages in the immunological diabetic process. Proc Natl Acad. Sci. 90: 8992-8995
11. Divecha N and Irvine RF(1995) Phospholipid signaling. Cell 80 269-278
12. Dypbukt JM, Ankarcrona MM, Burkitt M, Sjöholm A, Strom K, Orrenius S and Nicotera P. (1994) Different prooxidant levels stimulate growth, trigger apoptosis, or produce necrosis of insulin-secreting RINmSF cells. The role of intracellular polyamines. J Biol. Chem. 269. 30553-30560
13. Eizirik DL, Flodstrom M, Karlsen AE and Welsh N (1996) The harmony of the spheres inducible nitric oxide synthase and related genes in pancreatic β-cells. Diabetologia 39: 875-890.
14. Gopalakrishna R, Chen ZH and Gundimeda U (1993) Nitric oxide and nitric oxide-generating agents induce a reversible inactivation of protein kinase C activity and phorbol ester binding. J Biol Chem 268: 27180-27185
15. Hannun YA and Obeid LM (1995) Ceramide: an intracellular signal for apoptosis Trends Biochem. Sci 20 73-77
16. Hayward AR, Shriber M and Sokol R (1992) Vitamin E supplementation reduces the incidence of diabetes but not insulitis in NOD mice J. Lab. Clin. Med. 119: 503-507
17. Helgason T, Ewen SWB, Ross IS and Stowers JM (1982) Diabetes produced in mice by smoked/cured mutton Lancet ii: 1017-1022
18. Hussain MJ, Peakman M, Gallati H, Lo SS, Hawa M, Viberti GC, Watkins PJ, Leslie RDG, Vergani D (1996) Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM. Diabetologia 39: 60-69
19. Jiang Z and Woda BA (1991) Cytokine gene expression in the islets of the diabetic biobreeding/Worcester rat. J Immunol. 146: 2990-2994
20. 2+ channels exposed to serum from patients with type I diabetes. Science 261: 86-90
21. Kirstein M, Rivet-Bastide M, Hatem S, Bénardeau A, Mercadier J-J and Fischmeister R (1995) Nitric oxide regulates the calcium current in isolated human atrial myocytes. J. Clin. Invest 95: 794-802
22. Kostraba JN, Gay EC, Rewers M and Hamman RF (1992) Nitrate levels in community drinking waters and risk of IDDM. Diabetes Care 15: 1505-1508
23. Kurrer MO, Pakala SV, Hanson HL and Katz JD (1997) Beta cell apoptosis in T cell-mediated autoimmune diabetes Proc. Natl. Acad. Sci. 94: 213-218
24. 2+ channel activity by inositol hexakisphosphate Science 278: 471-474
25. Upton SA, Choi YB, Pan ZH, Lei SH, Chen HSV, Sucher NJ, Loscalzo J, Singel DJ and Stamler JS (1993) A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 364: 626-632
26. Mandrup-Poulsen T (1996) The role of interleukin-1 in the pathogenesis of IDDM. Diabetologia 39: 1005-1029
27. McDaniel ML, Kwon G, Hiil JR, Marshall CA and Corbett JA. (1996) Cytokines and nitric oxide in islet inflammation and diabetes. Proc. Soc. Exp. Biol. Med. 211: 24-32
28. Murthy VK, Shipp JC, Hanson C and Shipp DM (1992) Delayed onset and decreased incidence of diabetes in BB rats fed free radical scavengers Diab Res. Clin. Pract. 18: 11-16
29. Neer EJ (1995) Heterotrimeric G proteins: organizers of transmembrane signals. Cell 80: 249-257
30. Newgard CB and McGarry JD (1995) Metabolic coupling factors in pancreatic β-cell signal transduction. Ann. Rev. Biochem. 64: 689-719
31. Nishizuka Y (1995) Protein kinase C and lipid signaling for sustained cellular responses FASEB J. 9: 484-496
32. Robertson RP (1979) Prostaglandins as modulators of pancreatic islet function. Diabetes 28. 943-948
33. Robertson RP, Seaquist ER and Walseth TF (1991) G proteins and modulation of insulin secretion Diabetes 40: 1-6
34. + channels and diabetes mellitus News Physiol Sci. 5: 143-147.
35. Sandler S, Eizink DL, Svensson C, Strandell E, Welsh M and Welsh N. (1991) Biochemical and molecular actions of interleukin-1 on pancreatic β-cells. Autoimmunity 10: 241-253
36. Sjöholm Å (1991a) Inhibition of fetal rat pancreatic β-cell replication by interleukin-1β in vitro is not mediated through pertussis toxin-sensitive G-proteins, a decrease in cyclic AMP, or protease activation. FEBS Lett. 289: 249-252
37. Sjoholm Å (1991b) α-Adrenergic inhibition of rat pancreatic β-cell replication and insulin secretion is mediated through a pertussis toxin-sensitive G-protein regulating islet cAMP content. Biochem. Biophys. Res. Commun 180: 152-155
38. Sjoholm Å (1991c) Cytokines inhibit proliferation and insulin secretion by rat insulinoma cells (RINmSF) non-synergistically and in a pertussis toxin-insensitive manner. Immunol. Lett. 30: 81-86
39. Sjöhoim Å (1991d) Phorbol ester stimulation of pancreatic β-cell replication, polyamine content and insulin secretion. FEBS Lett. 294: 257-260
40. Sjöholm Å (1992a) Differential effects of cytokines on long-term mitogenic and secretory responses of fetal rat pancreatic β-cells. Am J. Physiol. 263: C114-C120
41. Sjöholm Å (1992b) Intracellular signal transduction pathways that control pancreatic β-cell proliferation. FEBS Lett. 311: 85-90
42. Sjöholm Å (1993) Invited review. Role of polyamines in the regulation of proliferation and hormone production by insulin-secreting cells. Am. J Physiol. 264: C501-C518
43. 2+, inositol phosphate generation, and phorbol ester sensitivity. J Clin Invest 92: 1910-1917
44. Sjöholm Å, Honkanen RE and Berggren P-O (1993b) Characterization of serine/ threonine protein phosphatases in insulin-secreting cells. Biosci Rep 13: 349-357
45. Sjöholm Å (1995) Ceramide inhibits pancreatic β-cell insulin production and mitogenesis and mimicks the actions of interleukin-1β. FEBS Lett 367:283-286
46. Sjöholm Å, Honkanen RE and Berggren P-O (1995) Inhibition of serine/threonine protein phosphatases by secretagogues in insulin-secreting cells. Endocrinology 136: 3391-3397
47. Sjöholm Å, (1996a) Interleukin-1β and GTP-binding proteins. Diabetologia 39: 243-244
48. Sjöholm Å (1996b) Effects of secretagogues on insulin biosynthesis and secretion in polyamine-depleted pancreatic β-cells. Am. J. Physiol 270: C1105-C1110
49. 2+ influx. Diabetes 45: 1057-1062
50. Sjöholm Å (1996d) Nitric oxide donor SIN-1 inhibits insulin release. Am. J. Physiol. 271: C1098-C1102
51. Sjöholm Å (1996e) Prostaglandins inhibit pancreatic β-cell replication and long-term insulin secretion by pertussis toxin-insensitive mechanisms but do not mediate the actions of interleukin-1β. Biochim. Biophys. Acta 1313: 106-110
52. Sjoholm Å (1997) Glucose stimulates islet β-cell mitogenesis through GTP-binding proteins and by protein kinase C-dependent mechanisms. Diabetes 46: 1141-1147
53. Southern C, Schulster D and Green IC (1990) Inhibition of insulin secretion by interleukin-1β and tumour necrosis factor-α via an L-arginine-dependent nitric oxide generating mechanism. FEBS Lett 276 42-44
54. Sperling MA (1997) Aspects of the etiology, prediction and prevention of insulin-dependent diabetes mellitus in childhood. Ped Clin. North. Amer. 44: 269-284
55. Stamler JS (1994) Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell 78: 931-936
56. Tisch R and McDevitt H (1996) Insulin-dependent diabetes mellitus. Cell 85: 291-297
57. Virtanen SM, Jaakkola L, Räsänen L, Ylönen K, Aro A, Lounamaa R, Åkerblom HK, Tuomilehto J and the Childhood Diabetes in Finland Study Group (1994) Nitrate and nitrite intake and the risk for type 1 diabetes in Finnish children Diabetic Medicine 11.656-662
58. Vyse TJ and Todd JA (1996) Genetic analysis of autoimmune disease. Cell 85:311-318
59. Welsh N, Eizink DL, Bendtzen K and Sandler S (1991a) Interleukin-1β-induced nitric oxide production in isolated rat pancreatic islets requires gene transcription and may lead to inhibition of the Krebs cycle enzyme aconitase. Endocrinology 129 3167-3173
60. Welsh N, Bendtzen K and Sandier S (1991b) Influence of protease on inhibitory and stimulatory effects of interleukin 1β on β-cell function. Diabetes 40: 290-294
61. Welsh N, Margulis B, Bendtzen K and Sandler S (1994a) Liposomal delivery of antioxidant enzymes protects against hydrogen peroxide-but not interleukin-1β-induced inhibition of glucose metabolism in rat pancreatic islets J. Endocrinol 143: 151-156
62. Welsh N, Eizink DL and Sandler S (1994b) Nitric oxide and pancreatic β-cell destruction in insulin-dependent diabetes meliitus: Don't take NO for an answer Autoimmunity 18: 285-290
63. Welsh N, Margulis B, Borg LAH, Jernberg Wiklund H, Saldeen J, Flodström M, Mello MA, Andersson A, Pipeleers DG, Hellerström C and Eizink DL (1995a) Differences in the expression of heat-shock proteins and antioxidant enzymes between human and rodent pancreatic islets: implications for the pathogenesis of insulin-dependent diabetes mellitus. Molecular Medicine 1: 806-820
64. Welsh N, Bendtzen K and Welsh M (1995b) Expression of an insulin/interteukin-1β receptor antagonist hybrid gene in insulin-producing cell lines (HIT-T15 and NIT-1) confers resistance against interleukin-1β-induced nitric oxide production. J Clin Invest 95: 1717-1722
65. 2-terminal kinase and transcription factor ATF2 in the insulin-producing cell line RINmSF. J Biol. Chem. 271: 8307-8312
66. Wollheim CB and Sharp GWG (1981) Regulation of insulin release by calcium. Physiol. Rev. 61. 914-973
67. zα, and other G-protein α-subunit messenger ribonucleic acids in pancreatic islets. Endocrinology 135: 31-37